INNO-GENE SA ZY -10 (WQ3) — Cash Flow Reinvestment Rate

Latest as of June 2025: 12.04x

INNO-GENE SA ZY -10 (WQ3) has a Cash Flow Reinvestment Rate of 12.04x as of June 2025, reinvesting €650.00K (capex €650.00K ) from operating cash flow of €54.00K. See WQ3 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

12.04x
(Capex + Investments) / Operating CF

Total Reinvested

€650.00K
Capex + Investments

Operating Cash Flow

€54.00K
EUR

Capital Expenditures

€650.00K
EUR

INNO-GENE SA ZY -10 Cash Flow Reinvestment Rate (2021–2022)

Historical reinvestment intensity for INNO-GENE SA ZY -10 across 2 annual periods. For the full cash flow conversion analysis, see INNO-GENE SA ZY -10 cash conversion from operations.

Annual Cash Flow Reinvestment Rate for INNO-GENE SA ZY -10 (2021–2022)

Year-by-year capital reinvestment analysis for INNO-GENE SA ZY -10. See WQ3 financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2022 104.36x €1.15 Million €11.00K €0.00 ▲ +31391.0%
2021 0.33x €2.24 Million €6.75 Million €82.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow